A Prospective Study of Fortiva in Hernia Repair

NCT06101979 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-07-25

No results posted yet for this study

Summary

The goal of this study is to evaluate safety and performance of the Fortiva Tissue Matrix. Participants will complete questionnaires to measure outcomes after hernia surgery for two years.

Conditions

  • Ventral Hernia
  • Incisional Hernia
  • Abdominal Wall Reconstruction

Interventions

DEVICE

Fortiva Tissue Matrix

Acellular Dermal Matrix used in hernia surgery

Sponsors & Collaborators

  • RTI Surgical

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-15
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06101979 on ClinicalTrials.gov